Last $0.0022 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 06/13/13 All times are local (Market data is delayed by at least 15 minutes).

xenacare holdings inc (XCHO) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/24/14 - $0.02
52 Week Low
01/6/14 - $0.0009
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for XENACARE HOLDINGS INC (XCHO)

Related News

No related news articles were found.

xenacare holdings inc (XCHO) Related Businessweek News

No Related Businessweek News Found

xenacare holdings inc (XCHO) Details

XenaCare Holdings, Inc. engages in the formulation, marketing, and distribution of clinical and protective nutrition supplement products (NSPs) in the United States. Its clinical NSP products include XenaCor, which lowers serum cholesterol, C-reactive protein, and homocysteine levels, designed to support cardiovascular health; XenaTri for lowering triglycerides and raising HDL to support cardiovascular health; and XenaZyme Plus that increases the body’s oxygen carrying capacities for supporting digestion. The company’s protective NSP offers formulations for the energy/lifestyle performance market comprising SunPill that is formulated to protect the skin when exposed to damaging ultraviolet rays. It also provides homeopathic medication products, such as Cobroxin, a pain reliever; and Zeolite, a cellular cleanse and detoxification product for removing heavy metals and toxins from the body. In addition, the company offers EstraPet, a natural hormone modulator, for treating the unintended consequences caused by spaying and neutering in domestic animals. It markets its products through direct response, catalogs, and mass food and drug retailers, as well as through online and infomercials. XenaCare Holdings, Inc. was founded in 2001 and is headquartered in Boca Raton, Florida.

6 Employees
Last Reported Date: 05/23/11
Founded in 2001

xenacare holdings inc (XCHO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

xenacare holdings inc (XCHO) Key Developments

SEC Orders Hearings On Registration Suspension Or Revocation Against XenaCare Holdings, Inc. For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of XenaCare Holdings, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XCHO:US $0.00 USD 0.00

XCHO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for XCHO.
View Industry Companies

Industry Analysis


Industry Average

Valuation XCHO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENACARE HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at